Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    RxSight Inc.

    NASDAQ: RXST · Real-Time Price · USD
    14.06
    -0.15 (-1.06%)
    At close: Jun 16, 2025, 3:59 PM

    RxSight Statistics

    Share Statistics

    RxSight has 40.64M shares outstanding. The number of shares has increased by 3.87% in one year.

    Shares Outstanding

    n/a
    		 40.64M

    Shares Change (YoY)

    n/a
    		 3.87%

    Shares Change (QoQ)

    n/a
    		 0.46%

    Owned by Institutions (%)

    n/a
    		 88.77%

    Shares Floating

    n/a
    		 37.76M

    Failed to Deliver (FTD) Shares

    n/a
    		 26

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 4.78M, so 11.76% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 4.78M

    Short % of Shares Out

    n/a
    		 11.76%

    Short % of Float

    n/a
    		 12.35%

    Short Ratio (days to cover)

    n/a
    		 5.1

    Valuation Ratios

    The PE ratio is -48.67 and the forward PE ratio is -26.79. RxSight's PEG ratio is 0.98.

    PE Ratio

    n/a
    		 -48.67

    Forward PE

    n/a
    		 -26.79

    PS Ratio

    n/a
    		 9.55

    Forward PS

    n/a
    		 2.4

    PB Ratio

    n/a
    		 4.75

    P/FCF Ratio

    n/a
    		 -59.69

    PEG Ratio

    n/a
    		 0.98
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for RxSight.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 11.36, with a Debt / Equity ratio of 0.04.

    Current Ratio

    n/a
    		 11.36

    Quick Ratio

    n/a
    		 10.5

    Debt / Equity

    n/a
    		 0.04

    Debt / EBITDA

    n/a
    		 -0.52

    Debt / FCF

    n/a
    		 -0.55

    Interest Coverage

    n/a
    		 -1755.14

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $280,977.91

    Profits Per Employee

    n/a
    		 $-55,130.52

    Employee Count

    n/a
    		 498

    Asset Turnover

    n/a
    		 0.44

    Inventory Turnover

    n/a
    		 1.86

    Taxes

    Income Tax

    n/a
    		 50K

    Effective Tax Rate

    n/a
    		 -0.18%

    Stock Price Statistics

    The stock price has increased by -74.94% in the last 52 weeks. The beta is 1.29, so RxSight's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.29

    52-Week Price Change

    n/a
    		 -74.94%

    50-Day Moving Average

    n/a
    		 14.89

    200-Day Moving Average

    n/a
    		 33.5

    Relative Strength Index (RSI)

    n/a
    		 39.84

    Average Volume (20 Days)

    n/a
    		 1,032,944

    Income Statement

    In the last 12 months, RxSight had revenue of 139.93M and earned -27.45M in profits. Earnings per share was -0.71.

    Revenue

    n/a
    		 139.93M

    Gross Profit

    n/a
    		 98.94M

    Operating Income

    n/a
    		 -36.86M

    Net Income

    n/a
    		 -27.45M

    EBITDA

    n/a
    		 -23.76M

    EBIT

    n/a
    		 -27.38M

    Earnings Per Share (EPS)

    n/a
    		 -0.71
    Full Income Statement

    Balance Sheet

    The company has 16.71M in cash and 12.3M in debt, giving a net cash position of 4.41M.

    Cash & Cash Equivalents

    n/a
    		 16.71M

    Total Debt

    n/a
    		 12.3M

    Net Cash

    n/a
    		 4.41M

    Retained Earnings

    n/a
    		 -622.1M

    Total Assets

    n/a
    		 313.04M

    Working Capital

    n/a
    		 265.67M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -16.95M and capital expenditures -5.44M, giving a free cash flow of -22.39M.

    Operating Cash Flow

    n/a
    		 -16.95M

    Capital Expenditures

    n/a
    		 -5.44M

    Free Cash Flow

    n/a
    		 -22.39M

    FCF Per Share

    n/a
    		 -0.58
    Full Cash Flow Statement

    Margins

    Gross margin is 70.71%, with operating and profit margins of -26.34% and -19.62%.

    Gross Margin

    n/a
    		 70.71%

    Operating Margin

    n/a
    		 -26.34%

    Pretax Margin

    n/a
    		 -19.59%

    Profit Margin

    n/a
    		 -19.62%

    EBITDA Margin

    n/a
    		 -16.98%

    EBIT Margin

    n/a
    		 -26.34%

    FCF Margin

    n/a
    		 -16%

    Dividends & Yields

    RXST does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for RXST is $32, which is 127.6% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $32

    Price Target Difference

    n/a
    		 127.6%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 10
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 10.13

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist